INDICATIONS AND USAGE
If you are a patient experiencing problems with a Sanofi US product, please
contact Sanofi US at .
The health information contained herein is provided for general educational purposes
only. Your healthcare professional is the single best source of information
regarding your health. Please consult your healthcare professional if you have any
questions about your health or treatment.
Back to the top ▲
© 2021 sanofi‐aventis US LLC. All rights reserved.
This site is intended for use by US Healthcare Professionals only.
MAT-US-2006908-v3.0-06/2021 Last Updated: June 2021
Please note: By clicking on this link, you will be
leaving this Sanofi US website and going to another, entirely
independent, website. Sanofi US provides these links as a service to
their website visitors and users; however, the Company takes no
responsibility for the information on any website but their own.
Click the “Continue” button below to go to the page
you requested or click “Cancel” to remain on this
IMPORTANT SAFETY INFORMATION
WARNING: FETAL TOXICITY
pregnancy is detected, discontinue AVAPRO or AVALIDE as soon as
possible. Drugs that act directly on the renin-angiotensin system can
cause injury and death to the developing fetus. full Prescribing Information for
AVAPRO and AVALIDE for complete Boxed Warnings.